These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9989373)

  • 1. Comparison of the effects of pravastatin and lovastatin on sleep disturbance in hypercholesterolemic subjects.
    Ehrenberg BL; Lamon-Fava S; Corbett KE; McNamara JR; Dallal GE; Schaefer EJ
    Sleep; 1999 Feb; 22(1):117-21. PubMed ID: 9989373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central nervous system effects of HMG CoA reductase inhibitors: lovastatin and pravastatin on sleep and cognitive performance in patients with hypercholesterolemia.
    Kostis JB; Rosen RC; Wilson AC
    J Clin Pharmacol; 1994 Oct; 34(10):989-96. PubMed ID: 7836550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of lovastatin and pravastatin on sleep efficiency and sleep stages.
    Vgontzas AN; Kales A; Bixler EO; Manfredi RL; Tyson KL
    Clin Pharmacol Ther; 1991 Dec; 50(6):730-7. PubMed ID: 1752118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of effects on sleep of lovastatin and pravastatin in hypercholesterolemia.
    Partinen M; Pihl S; Strandberg T; Vanhanen H; Murtomäki E; Block G; Neafus R; Haigh J; Miettinen T; Reines S
    Am J Cardiol; 1994 May; 73(12):876-80. PubMed ID: 8184812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-related decrease of serum coenzyme Q10 during treatment with HMG-CoA reductase inhibitors.
    Mortensen SA; Leth A; Agner E; Rohde M
    Mol Aspects Med; 1997; 18 Suppl():S137-44. PubMed ID: 9266515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of simvastatin and pravastatin on objective and subjective measures of nocturnal sleep: a comparison of two structurally different HMG CoA reductase inhibitors in patients with primary moderate hypercholesterolaemia.
    Eckernäs SA; Roos BE; Kvidal P; Eriksson LO; Block GA; Neafus RP; Haigh JR
    Br J Clin Pharmacol; 1993 Mar; 35(3):284-9. PubMed ID: 8471404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative evaluation of the safety and efficacy of HMG-CoA reductase inhibitor monotherapy in the treatment of primary hypercholesterolemia.
    Hsu I; Spinler SA; Johnson NE
    Ann Pharmacother; 1995; 29(7-8):743-59. PubMed ID: 8520093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicenter comparative trial of lovastatin and pravastatin in the treatment of hypercholesterolemia. The Lovastatin Pravastatin Study Group.
    Am J Cardiol; 1993 Apr; 71(10):810-5. PubMed ID: 8456759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of treatment with lovastatin and pravastatin on daytime cognitive performance.
    Gengo F; Cwudzinski D; Kinkel P; Block G; Stauffer L; Lines C
    Clin Cardiol; 1995 Apr; 18(4):209-14. PubMed ID: 7788948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence of plasma CoQ10-lowering effect by HMG-CoA reductase inhibitors: a double-blind, placebo-controlled study.
    Ghirlanda G; Oradei A; Manto A; Lippa S; Uccioli L; Caputo S; Greco AV; Littarru GP
    J Clin Pharmacol; 1993 Mar; 33(3):226-9. PubMed ID: 8463436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of pravastatin and lovastatin on nighttime sleep and daytime performance.
    Roth T; Richardson GR; Sullivan JP; Lee RM; Merlotti L; Roehrs T
    Clin Cardiol; 1992 Jun; 15(6):426-32. PubMed ID: 1617822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the short-term efficacy and tolerability of lovastatin and pravastatin in the management of primary hypercholesterolemia.
    McPherson R; Bedard J; Connelly P; Curnew G; Davignon J; Echenberg D; Lavin P; Leiter L; Lenis J; McQueen M
    Clin Ther; 1992; 14(2):276-91. PubMed ID: 1611649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pravastatin sodium, a new HMG-CoA reductase inhibitor.
    Raasch RH
    DICP; 1991 Apr; 25(4):388-94. PubMed ID: 1926908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do cholesterol-lowering agents affect brain activity? A comparison of simvastatin, pravastatin, and placebo in healthy volunteers.
    Harrison RW; Ashton CH
    Br J Clin Pharmacol; 1994 Mar; 37(3):231-6. PubMed ID: 8198930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effects of two HMG-CoA reductase inhibitors (lovastatin and pravastatin) on serum lipids and lipoproteins.
    Richter WO; Jacob BG; Schwandt P
    Int J Tissue React; 1991; 13(2):107-10. PubMed ID: 1955291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of lovastatin and pravastatin on cognitive function in military aircrew.
    Gibellato MG; Moore JL; Selby K; Bower EA
    Aviat Space Environ Med; 2001 Sep; 72(9):805-12. PubMed ID: 11565814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of 2 cholesterol synthesis inhibitors (simvastatin and pravastatin)].
    Golay A; Lehmann T; James R; Pometta D
    Schweiz Med Wochenschr; 1993 Aug; 123(33):1553-8. PubMed ID: 8372340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the HMG-CoA reductase inhibitors on blood pressure in patients with essential hypertension and primary hypercholesterolemia.
    Glorioso N; Troffa C; Filigheddu F; Dettori F; Soro A; Parpaglia PP; Collatina S; Pahor M
    Hypertension; 1999 Dec; 34(6):1281-6. PubMed ID: 10601131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pravastatin, simvastatin, and lovastatin for lowering serum cholesterol concentrations.
    Med Lett Drugs Ther; 1992 Jun; 34(872):57-8. PubMed ID: 1593973
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative efficacy and tolerability of 5 and 10 mg simvastatin and 10 mg pravastatin in moderate primary hypercholesterolemia. Simvastatin Pravastatin European Study Group.
    Steinhagen-Thiessen E
    Cardiology; 1994; 85(3-4):244-54. PubMed ID: 7987882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.